Tumor Lysis Syndrome in Patients Treated with Chimeric Antigen Receptor T-cell Therapy: A Retrospective Study
Anand Kadakia, Jiahua Zhang, Mrunal Patel, Freya Shah, Fnu Anamika, Akshit Chitkara & Rushin Patel · Journal of Cancer and Tumor International · 2026
Background: Chimeric antigen receptor T-cell (CAR T-cell) therapy has revolutionised cancer treatment, particularly for relapsed or refractory haematological malignancies. However, treatment-related toxicities, including tumour lysis syndrome (TLS), remain a significant concern....
Open access
Research Article
10.9734/jcti/2026/v16i3363